These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35716463)

  • 41. Analysis of potential genotoxic impurities in rabeprazole active pharmaceutical ingredient via Liquid Chromatography-tandem Mass Spectrometry, following quality-by-design principles for method development.
    Iliou K; Malenović A; Loukas YL; Dotsikas Y
    J Pharm Biomed Anal; 2018 Feb; 149():410-418. PubMed ID: 29154196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification of flavonoids from licorice using an off-line preparative two-dimensional normal-phase liquid chromatography/reversed-phase liquid chromatography method.
    Fan Y; Fu Y; Fu Q; Cai J; Xin H; Dai M; Jin Y
    J Sep Sci; 2016 Jul; 39(14):2710-9. PubMed ID: 27214649
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening of complex natural extracts by countercurrent chromatography using a parallel protocol.
    Lu Y; Berthod A; Hu R; Ma W; Pan Y
    Anal Chem; 2009 May; 81(10):4048-59. PubMed ID: 19331393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isopropylammonium formate as a mobile phase modifier for liquid chromatography.
    Collins MP; Zhou L; Camp SE; Danielson ND
    J Chromatogr Sci; 2012; 50(10):869-76. PubMed ID: 22718743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of an achiral supercritical fluid chromatography method with ultraviolet absorbance and mass spectrometric detection for impurity profiling of drug candidates. Part I: Optimization of mobile phase composition.
    Lemasson E; Bertin S; Hennig P; Boiteux H; Lesellier E; West C
    J Chromatogr A; 2015 Aug; 1408():217-26. PubMed ID: 26195034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Centrifugal partition chromatography: A preparative tool for isolation and purification of xylindein from Chlorociboria aeruginosa.
    Boonloed A; Weber GL; Ramzy KM; Dias VR; Remcho VT
    J Chromatogr A; 2016 Dec; 1478():19-25. PubMed ID: 27919517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification of drug degradation products supported by analytical and preparative supercritical fluid chromatography.
    Noireau A; Lemasson E; Mauge F; Petit AM; Bertin S; Hennig P; Lesellier É; West C
    J Pharm Biomed Anal; 2019 Jun; 170():40-47. PubMed ID: 30904738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversed-phase liquid chromatography system constant database over an extended mobile phase composition range for 25 siloxane-bonded silica-based columns.
    Poole CF
    J Chromatogr A; 2019 Aug; 1600():112-126. PubMed ID: 31128882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The acetonitrile shortage: is reversed HILIC with water an alternative for the analysis of highly polar ionizable solutes?
    dos Santos Pereira A; David F; Vanhoenacker G; Sandra P
    J Sep Sci; 2009 Jun; 32(12):2001-7. PubMed ID: 19479755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Model-based design of gradient elution in liquid-liquid chromatography: Application to the separation of cannabinoids.
    Gerigk M; Luca SV; Schwarzenbach S; Minceva M
    J Chromatogr A; 2024 May; 1722():464888. PubMed ID: 38613932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Separation of chiral pharmaceutical drugs by chromatographic and electrophoretic techniques].
    Morin P
    Ann Pharm Fr; 2009 Jul; 67(4):241-50. PubMed ID: 19596097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Solvatochromic parameter values and pH in acetonitrile-water mixtures. Optimization of mobile phase for the separation of peptides by high-performance liquid chromatography.
    Barbosa J; Sanz-Nebot V; Toro I
    J Chromatogr A; 1996 Feb; 725(2):249-60. PubMed ID: 8900575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid and high throughput separation technologies--steady state recycling and supercritical fluid chromatography for chiral resolution of pharmaceutical intermediates.
    Yan TQ; Orihuela C
    J Chromatogr A; 2007 Jul; 1156(1-2):220-7. PubMed ID: 17449051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive analysis of pharmaceutical products using simultaneous mixed-mode (ion-exchange/reversed-phase) and hydrophilic interaction liquid chromatography.
    Kazarian AA; Nesterenko PN; Soisungnoen P; Burakham R; Srijaranai S; Paull B
    J Sep Sci; 2014 Aug; 37(16):2138-44. PubMed ID: 24890905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparative enantiomer separation of dichlorprop with a cinchona-derived chiral selector employing centrifugal partition chromatography and high-performance liquid chromatography: a comparative study.
    Gavioli E; Maier NM; Minguillón C; Lindner W
    Anal Chem; 2004 Oct; 76(19):5837-48. PubMed ID: 15456305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enrichment and purification of peptide impurities using twin-column continuous chromatography.
    Weldon R; Müller-Späth T
    J Chromatogr A; 2022 Mar; 1667():462894. PubMed ID: 35219108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening approach for chiral separation of pharmaceuticals. Part III. Supercritical fluid chromatography for analysis and purification in drug discovery.
    Maftouh M; Granier-Loyaux C; Chavana E; Marini J; Pradines A; Heyden YV; Picard C
    J Chromatogr A; 2005 Sep; 1088(1-2):67-81. PubMed ID: 16130734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid Method Development in Hydrophilic Interaction Liquid Chromatography for Pharmaceutical Analysis Using a Combination of Quantitative Structure-Retention Relationships and Design of Experiments.
    Taraji M; Haddad PR; Amos RI; Talebi M; Szucs R; Dolan JW; Pohl CA
    Anal Chem; 2017 Feb; 89(3):1870-1878. PubMed ID: 28208251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.